ARCUTIS BIOTHERAPEUTIC
10.15
20-September-24 15:59:59
15 minutes delayed
Stocks
+0.01
+0.10%
Today's range
9.78 - 10.31
ISIN
N/A
Source
NASDAQ
-
Arcutis to Present at Upcoming Investor Conference
12 Apr 2023 16:45:00 By Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07 Apr 2023 16:00:00 By Nasdaq GlobeNewswire
-
05 Apr 2023 08:00:00 By Nasdaq GlobeNewswire
-
18 Mar 2023 07:00:00 By Nasdaq GlobeNewswire
-
09 Mar 2023 08:00:01 By Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 Mar 2023 16:00:00 By Nasdaq GlobeNewswire
-
Arcutis Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
28 Feb 2023 16:02:00 By Nasdaq GlobeNewswire
-
21 Feb 2023 08:00:01 By Nasdaq GlobeNewswire
-
08 Feb 2023 08:00:01 By Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 Feb 2023 16:09:57 By Nasdaq GlobeNewswire
-
14 Jan 2023 04:00:00 By Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 Jan 2023 16:00:00 By Nasdaq GlobeNewswire
-
12 Dec 2022 08:00:53 By Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 Dec 2022 16:01:00 By Nasdaq GlobeNewswire
-
Arcutis Enrolls First Patient in Phase 1b Alopecia Areata Study Evaluating ARQ-255
05 Dec 2022 08:00:00 By Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Publishes First Environmental, Social, and Governance (ESG) Report
21 Nov 2022 09:15:00 By Nasdaq GlobeNewswire
-
15 Nov 2022 08:00:02 By Nasdaq GlobeNewswire